Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial, Nancy G. Klimas, M. Holodniy, S. T. Brown, D. W. Cameron, T. C. Kyriakides, B. Angus, A. Babiker, J. Singer, D. K. Owens, A. Anis, R. Goodall, F. Hudson, M. Piaseczny, J. Russo, M. Schenchter, L. Deyton, J. Darbyshire
Faculty Articles

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Nancy G. Klimas, J. D. Lundgren, A. Babiker, W. El-Sadr, S. Emery, B. Grund, J. D. Neaton, J. Neuhaus, A. Phillips
Faculty Articles

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study, Nancy G. Klimas, S. Emery, J. A. Neuhaus, A. N. Phillips, A. Babiker, C. J. Cohen, J. M. Gatell, P. M. Girard, B. Grund, M. Law, M. H. Losso, A. Palfreeman, R. Wood
Faculty Articles

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial, Nancy G. Klimas, W. M. El-Sadr, B. Grund, J. Neuhaus, A. Babiker, C. J. Cohen, J. Darbyshire, S. Emery, J. D. Lundgren, A. Phillips, J. D. Neaton
Faculty Articles